Novartis to Buy Myricx Bio for Up to $1.5 Billion
The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities.
Connecting Global Economies
Your blog category
The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities.
TeraWulf will partner with Anthropic to build an artificial-intelligence infrastructure campus in Kentucky that could generate $19 billion in revenue.
The videogame unit’s revenue has fallen and its Netflix-like subscription service is far below expectations.
Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
António Guterres labels lethal autonomous weapons “morally repugnant,” resurfacing issue that was central to Anthropic’s clash with the Pentagon.
Governments consistently fail to deliver on their promises. Technology can help them do better.
Through adaptation and superior technology, Kyiv weakens Russia by cumulative disruption.
The acquisition would add to Vertex’s pipeline and potentially grow its annual revenue by $5 billion with the addition of Crinetics-developed drugs Palsonify and Atumelnant, the company said.
Six people reveal what’s in their compact bags of calming tools, including fidget toys, sour candies and a rosary.
Shares of the veteran handset maker have surged roughly 90% this year as it pivots to become a heavyweight infrastructure supplier.